The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Discovery of potent, orally active KIF18A inhibitors targeting CIN-high cancer cells.
 
Rumin Zhang
Employment - Volastra Therapeutics
Stock and Other Ownership Interests - Volastra Therapeutics
Patents, Royalties, Other Intellectual Property - Volastra Therapeutics
 
Derek Cogan
Employment - Volastra Therapeutics
Patents, Royalties, Other Intellectual Property - Volastra Therapeutics
 
Christina Eng
Employment - Pfizer; Volastra Therapeutics
Stock and Other Ownership Interests - Pfizer
 
Aaron Phillips
Employment - CareMount Medical (I); Volastra Therapeutics
Research Funding - Inzen Therapeutics
 
Marysol Chu Carty
No Relationships to Disclose
 
Tamar Feinberg
Employment - Volastra Therapeutics
 
Akanksha Verma
Employment - Volastra Therapeutics
Stock and Other Ownership Interests - Volastra Therapeutics
Consulting or Advisory Role - Volastra Therapeutics
Patents, Royalties, Other Intellectual Property - Volastra Therapeutics
 
Richard Tourdot
Employment - Volastra Therapeutics
 
Albert Swiston
Employment - Merck; Takeda (I); Volastra Therapeutics
Leadership - Volastra Therapeutics
Stock and Other Ownership Interests - Merck; Takeda (I)
Patents, Royalties, Other Intellectual Property - MIT
 
Sarah Bettigole
Employment - Volastra Therapeutics
Stock and Other Ownership Interests - Volastra Therapeutics
 
Scott Drutman
Employment - Regeneron; Volastra Therapeutics
Stock and Other Ownership Interests - Volastra Therapeutics
 
Michael Su
Employment - Volastra Therapeutics
Leadership - Volastra Therapeutics
Stock and Other Ownership Interests - Volastra Therapeutics
Consulting or Advisory Role - Agios; Auron Therapeutics; Rheos Medicines
Patents, Royalties, Other Intellectual Property - Volastra Therapeutics